J Świȩs

930 total citations
27 papers, 771 citations indexed

About

J Świȩs is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, J Świȩs has authored 27 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in J Świȩs's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Receptor Mechanisms and Signaling (6 papers) and Inflammatory mediators and NSAID effects (6 papers). J Świȩs is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Receptor Mechanisms and Signaling (6 papers) and Inflammatory mediators and NSAID effects (6 papers). J Świȩs collaborates with scholars based in Poland, Sweden and United States. J Świȩs's co-authors include Ryszard J. Gryglewski, Ryszard Korbut, Jadwiga Robak, Stefan Chłopicki, Magdalena Łomnicka, Jan Adamus, Jerzy Gębicki, Andrzej Mogielnicki, Magdalena Bartuś and W Buczko and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

J Świȩs

27 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Świȩs Poland 12 208 181 153 112 103 27 771
Francis I. Achike Malaysia 13 213 1.0× 109 0.6× 156 1.0× 204 1.8× 115 1.1× 34 770
Marta Chataigneau France 7 158 0.8× 324 1.8× 74 0.5× 150 1.3× 50 0.5× 9 758
Inmaculada Concepción Villar United Kingdom 13 240 1.2× 248 1.4× 136 0.9× 232 2.1× 68 0.7× 20 910
Suvara K. Wattanapitayakul Thailand 15 311 1.5× 127 0.7× 207 1.4× 203 1.8× 71 0.7× 32 1.0k
Noorafza Q. Khan United Kingdom 12 289 1.4× 263 1.5× 121 0.8× 247 2.2× 46 0.4× 18 930
N. Dousset France 16 298 1.4× 274 1.5× 83 0.5× 134 1.2× 59 0.6× 57 1.1k
Federica Lodi Spain 18 373 1.8× 298 1.6× 169 1.1× 252 2.3× 52 0.5× 27 1.0k
W Bernini Italy 17 260 1.3× 203 1.1× 293 1.9× 221 2.0× 145 1.4× 39 1.3k
Gibanananda Ray United States 18 631 3.0× 166 0.9× 220 1.4× 108 1.0× 57 0.6× 21 1.4k
Antonio Zarzuelo Spain 9 180 0.9× 158 0.9× 64 0.4× 158 1.4× 45 0.4× 12 549

Countries citing papers authored by J Świȩs

Since Specialization
Citations

This map shows the geographic impact of J Świȩs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Świȩs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Świȩs more than expected).

Fields of papers citing papers by J Świȩs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Świȩs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Świȩs. The network helps show where J Świȩs may publish in the future.

Co-authorship network of co-authors of J Świȩs

This figure shows the co-authorship network connecting the top 25 collaborators of J Świȩs. A scholar is included among the top collaborators of J Świȩs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Świȩs. J Świȩs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chłopicki, Stefan, J Świȩs, Andrzej Mogielnicki, et al.. (2007). 1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway. British Journal of Pharmacology. 152(2). 230–239. 172 indexed citations
2.
Gryglewski, R.J., Stefan Chłopicki, & J Świȩs. (2004). In vivo endothelial interaction between ACE and COX inhibitors. Prostaglandins Leukotrienes and Essential Fatty Acids. 72(2). 129–131. 12 indexed citations
3.
Gryglewski, R.J., J Świȩs, W Uracz, Stefan Chłopicki, & E Marcinkiewicz. (2003). Mechanisms of angiotensin-converting enzyme inhibitor induced thrombolysis in Wistar rats. Thrombosis Research. 110(5-6). 323–329. 20 indexed citations
4.
Gryglewski, Ryszard J., et al.. (2002). Synthesis and thrombolytic activity of new thienopyrimidinone derivatives.. PubMed. 53(4 Pt 1). 625–34. 15 indexed citations
5.
Gryglewski, Ryszard J., W Uracz, J Świȩs, et al.. (2001). Comparison of Endothelial Pleiotropic Actions of Angiotensin Converting Enzyme Inhibitors and Statins. Annals of the New York Academy of Sciences. 947(1). 229–246. 33 indexed citations
6.
Gryglewski, Ryszard J., et al.. (2000). Thrombolysis by thienopyridines and their congeners.. PubMed. 51(4 Pt 1). 683–93. 11 indexed citations
7.
Rj, Gryglewski, Ryszard Korbut, J Świȩs, & W Uracz. (1999). Effect of ticlopidine on streptokinase-induced thrombolysis in rats.. PubMed. 111(3). 98–102. 7 indexed citations
8.
Korbut, Ryszard, J Świȩs, E Marcinkiewicz, & Ryszard J. Gryglewski. (1998). Thrombolytic activity of beta-adrenolytic drug, sotalol.. PubMed. 49(1). 51–60. 6 indexed citations
9.
Gryglewski, Ryszard J., et al.. (1996). Thrombolytic action of ticlopidine: possible mechanisms. European Journal of Pharmacology. 308(1). 61–67. 35 indexed citations
10.
Rj, Gryglewski & J Świȩs. (1995). Streptokinase-prostacyclin--nitric oxide: in vivo interactions.. PubMed. 23. 479–84. 2 indexed citations
11.
Świȩs, J, et al.. (1992). Cardioprotection by Molsidomine and Iloprost in Myocardial Ischaemia in Anaesthetized Cats. Birkhäuser Basel eBooks. 37. 265–272. 2 indexed citations
12.
Świȩs, J, Eric K. I. Omogbai, & Gene M. Smith. (1990). Occlusion and Reperfusion-Induced Arrhythmias in Rats. Journal of Cardiovascular Pharmacology. 15(5). 816–825. 24 indexed citations
13.
Świȩs, J, Marek W. Radomski, A. Dembińska-Kieć, et al.. (1985). Stimulatory cholinergic effect on the release of antiaggregatory activity into the circulation of cat and man and its modification by β‐adrenergic antagonists. European Journal of Clinical Investigation. 15(6). 320–326. 1 indexed citations
14.
Grodzińska, L, et al.. (1985). The Influence of Molsidomine and Its Active Metabolite SIN-1 on Fibrinolysis and Platelet Aggregation. Thrombosis and Haemostasis. 54(4). 746–749. 9 indexed citations
15.
Świȩs, J, et al.. (1985). Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro.. PubMed. 36(5). 455–63. 20 indexed citations
16.
Świȩs, J, et al.. (1985). Release of disaggregatory prostanoids into circulation by nicotinic alcohol, nicotinic acid and nicotinamide.. PubMed. 36(6). 653–7. 2 indexed citations
17.
Świȩs, J, Marek W. Radomski, & Ryszard J. Gryglewski. (1981). On the mechanism of angiotensin II induced release of prostacyclin. Pharmacological Research Communications. 13(1). 37–40. 2 indexed citations
18.
Radomski, Marek W., J Świȩs, & R.J. Gryglewski. (1981). Disaggregatory action of phosphodiesterase inhibitors. Pharmacological Research Communications. 13(1). 41–47. 5 indexed citations
19.
Świȩs, J, Marek W. Radomski, & Ryszard J. Gryglewski. (1979). Angiotensin-induced release of prostacyclin (PGI2) into circulation of anaesthetized cats. Pharmacological Research Communications. 11(8). 649–655. 16 indexed citations
20.
Świȩs, J. (1976). Haemodynamic changes accompanying lung oedema produced by iv injection of adrenaline or vasopressin into rats.. PubMed. 28(4). 335–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis I. Achike Breakdown of academic impact, for papers by Marta Chataigneau Breakdown of academic impact, for papers by Inmaculada Concepción Villar Breakdown of academic impact, for papers by Suvara K. Wattanapitayakul Breakdown of academic impact, for papers by Noorafza Q. Khan Breakdown of academic impact, for papers by N. Dousset Breakdown of academic impact, for papers by Federica Lodi Breakdown of academic impact, for papers by W Bernini Breakdown of academic impact, for papers by Gibanananda Ray Breakdown of academic impact, for papers by Antonio Zarzuelo
Rankless by CCL
2026